{"id":538787,"date":"2021-09-15T16:04:07","date_gmt":"2021-09-15T20:04:07","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/biovie-to-present-at-oppenheimer-fall-healthcare-life-sciences-medtech-virtual-summit\/"},"modified":"2021-09-15T16:04:07","modified_gmt":"2021-09-15T20:04:07","slug":"biovie-to-present-at-oppenheimer-fall-healthcare-life-sciences-medtech-virtual-summit","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/biovie-to-present-at-oppenheimer-fall-healthcare-life-sciences-medtech-virtual-summit\/","title":{"rendered":"BioVie to Present at Oppenheimer Fall Healthcare Life Sciences &amp; MedTech Virtual Summit"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"justify\">SANTA MONICA, Calif., Sept.  15, 2021  (GLOBE NEWSWIRE) &#8212; BioVie Inc., (NASDAQ: BIVI) (\u201cBioVie\u201d or the \u201cCompany\u201d) a clinical-stage company developing innovative drug therapies for the treatment of neurodegenerative disorders and advanced liver disease, today announced the participation of its management team in the Oppenheimer Fall Healthcare Life Sciences &amp; MedTech Virtual Summit September 22, 2021.<\/p>\n<p>Details on the conference can be found below.<\/p>\n<p>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0<strong>Oppenheimer Fall Healthcare Life Sciences &amp; MedTech Virtual Summit<\/strong>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0<br \/>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0Format: BioVie Update &amp; Overview<br \/>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0Date: Wednesday September 22, 2021<br \/>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0Presentation time: 12:25 p.m. EST<br \/>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0Webcast: <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=GTUjSlBPHn_ajNpBsTsZHFWpn3Dr1jpdgFNmH45IVuqy_dyP72dEy3NOqK_NPwKFukNsr_2hS2UOWOPFLcuYaRSa9e7GdqPO-8UQ6UtBo1BGpfoJFMpDePWMUm0JfDAoDQ-OQ1lr5I7x-knq4W2OWR9fm2i_bPL59bLmChKFQcV85ZCi_Eu0KZBhlx0z9QS6s0Sug8x_zCUEn7efCdkQ3WSTOHbBSLhMfZrVxsQD9HpnNeSxpkf7XKCx9j29BGYD_jxDs2-rx2Of5VI7AeRBwDy76BYt5GwuOCq-giQ3rOHud62syhMC9fMSSbXIhh_0uzKJ9AIP2izi3RJ1rkUTc0aRRa96UiZ3mR0cEKuqCzrs8oWgIUv5NtQBsXaDYWbD4vJUrlXg8q8K2q21ijeo38AT1cB8C5PVlnG-kDhLX06W0OpoL8Un2M8rgGNiOUA-EZciAq-XDHtJuFIiMhXrMIusa6-_Ruc9pZVct48R81j7ApPvViyuQhPls-KjqP1ctbEW_dphSmM6nN8Z045RxWdH1OavPHAhahowSpWtHwZ-HmQ2ijEW3wckscreZKSgppUhqRyEa5CGTkKoJ-uIGWm0VBUEsS9h45VnQf2mPFIrPFNOD8Z0ESfsUjdbp7P6YyEq8BV6WCWP0vVmAvKG3h_D9OiCfDxEFcV1LKnTzASNMzx9lof8eVA033rY3gAfdnLOiMBrOEI2kejC034RMRZSKrdi6y5wBnuWf6dlL3dO8vkhdpoWV1C1Ox3QeDpQ0d7vWT4t56xTQkE9_RkC5YQEDsI2HEc_jIcPUIX81ZhS_zp4ImS4E3tIpta9v_aU4DV3WFKbO5_Rz5qs97eiRaxLebrFulAxeZP9ZUUVCMM=\" rel=\"nofollow noopener\" target=\"_blank\">https:\/\/wsw.com\/webcast\/oppenheimer16\/bivi\/2769630<\/a><\/p>\n<p>An archived webcast will also be accessible in the <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=e6rB9yOVegary3LK2BNrIAvMsgbadXb13G1Oo0EkXGcGk_-jjObarcLSiJvKtNurN4yqgyJrhmdFk6vDDw8Vkv9psC8yssEk6gEX6TOjZb6EORWILV6aOg_IPFmqIyDfulF3vbrvRo2ylvqOkKS9zA==\" rel=\"nofollow noopener\" target=\"_blank\">Investors<\/a> section of the company\u2019s website at <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=0agCQkq_SbsMKlX-l10FPlTK8IcdAgfr1SSFjtr1ejL3UEApWkJn3ydnP0rUFFLEnVygTcm4zjcYMAL3mXfcfc57KHZ3_YX8UxiAMm6ew7Q=\" rel=\"nofollow noopener\" target=\"_blank\">www.bioviepharma.com<\/a>.<\/p>\n<p align=\"justify\">\n        <strong>About BioVie <\/strong>\n      <\/p>\n<p align=\"justify\">BioVie Inc. (NASDAQ: BIVI) is a clinical-stage company developing transformative therapies to overcome unmet medical needs in chronic debilitating conditions. In liver disease, the Company\u2019s Orphan drug candidate BIV201 (continuous infusion terlipressin), with FDA Fast Track status, is being evaluated in a US Phase 2 study for the treatment of refractory ascites with top-line results expected in early 2022. The Company is also planning a pivotal Phase 3 study of BIV201 in the treatment of hepatorenal syndrome-acute kidney injury (HRS-AKI) in 2022. BIV201 is administered as a patent-pending liquid formulation. The active agent is approved in about 40 countries for related complications of advanced liver cirrhosis but is not available in the US or Japan. In neurodegenerative disease, BioVie acquired the assets of NeurMedix Inc., including NE3107 that inhibits inflammatory activation of ERK and NFB (e.g. TNF transcription) that leads to neuroinflammation and insulin resistance, but not their homeostatic functions (e.g. insulin signaling and neuron growth and survival). Both are drivers of Alzheimer\u2019s and Parkinson\u2019s diseases. The Company is conducting a potentially pivotal Phase 3 randomized, double blind, placebo controlled, parallel group, multicenter study to evaluate NE3107 in subjects who have mild to moderate Alzheimer&#8217;s disease (NCT04669028). An estimated six million Americans suffer from Alzheimer\u2019s. BioVie has initiated this study and is targeting primary completion in late 2022. A Phase 2 study of NE3107 in Parkinson\u2019s disease is planned to start later this year, and related compounds have additional potential to treat certain cancers. NE3107 is patented in the United States, Australia, Canada, Europe and South Korea. For more information, visit\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=q_6kv6S8elW_qiimHNJ55eKOt4CutzAumAKI_qRl0uMe1vecKTXUPf4aHDRhBbsCIy9U85e8LhRP1znSuSqP0yE_EsnBvydC8xdXu7myx8RIvi3V7g46xG0YQ1MyiQnVNC262CbVvVgaMbB_SZNEjm40XpC3HpTtuUMvmOgKSk5tHVg0WYiXrZfGqccxQKjjUDABFwI4Tpd6fdgDk6tIppSU1L8jkxrLTgE21jDTFvz3Lhjc5rmZ20utX__-btEzOdM5l0AKNi8knTXXPX1QGA==\" rel=\"nofollow noopener\" target=\"_blank\">http:\/\/www.biovieinc.com\/<\/a>.<\/p>\n<p align=\"justify\">\n        <strong>Forward-Looking Statements<\/strong>\n      <\/p>\n<p align=\"justify\">\n        <em>This press release contains forward-looking statements, which may be identified by words such as &#8220;expect,&#8221; &#8220;look forward to,&#8221; &#8220;anticipate&#8221; &#8220;intend,&#8221; &#8220;plan,&#8221; &#8220;believe,&#8221; &#8220;seek,&#8221; &#8220;estimate,&#8221; &#8220;will,&#8221; &#8220;project&#8221; or words of similar meaning. Although BioVie Inc. believes such forward-looking statements are based on reasonable assumptions, it can give no assurance that its expectations will be attained. Actual results may vary materially from those expressed or implied by the statements herein due to the Company&#8217;s ability to successfully raise sufficient capital on reasonable terms or at all, available cash on hand and contractual and statutory limitations that could impair our ability to pay future dividends, our ability to\u00a0complete our clinical studies and to obtain approval for our product\u00a0candidates, to successfully defend potential future litigation, changes in local or national economic conditions<\/em>\u00a0<em>as well as various additional risks, many of which are now unknown and generally out of the Company&#8217;s control, and which are detailed from time to time in reports filed by the Company with the SEC, including quarterly reports on Form 10-Q, reports on Form 8-K and annual reports on Form 10-K. BioVie Inc. does not undertake any duty to update any statements contained herein (including any forward-looking statements), except as required by law.<\/em><\/p>\n<p align=\"justify\">\n        <strong><br \/>\n          <em>For Investor Relations Inquiries:<\/em><br \/>\n        <\/strong>\n      <\/p>\n<table style=\"border-collapse: collapse;width:100%;border-collapse:collapse\">\n<tr>\n<td style=\"vertical-align: top\">\u00a0<\/td>\n<td style=\"vertical-align: top\">\u00a0<\/td>\n<\/tr>\n<tr>\n<td style=\"vertical-align: top\">Contact:<br \/><strong>Bruce Mackle<\/strong><br \/><em>Managing Director<\/em><br \/><strong>LifeSci Advisors, LLC<\/strong><br \/><u><a href=\"mailto:bmackle@lifesciadvisors.com\" rel=\"nofollow noopener\" target=\"_blank\">bmackle@lifesciadvisors.com<\/a><\/u><\/td>\n<td>\u00a0<\/td>\n<\/tr>\n<tr>\n<td style=\"vertical-align: top\">\u00a0<\/td>\n<td>\u00a0<\/td>\n<\/tr>\n<tr>\n<td style=\"vertical-align: top\">\u00a0<\/td>\n<td>\u00a0<\/td>\n<\/tr>\n<\/table>\n<p>      <img decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODMyNjgwMiM0NDA3NzA4IzUwMDA3OTY2Ng==\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" src=\"https:\/\/ml.globenewswire.com\/media\/ZjNhNmU1YjYtOTVjMC00NmE0LWE1YWMtOTZjNDJmYzM1ODllLTUwMDA3OTY2Ng==\/tiny\/BioVie-Inc-.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>SANTA MONICA, Calif., Sept. 15, 2021 (GLOBE NEWSWIRE) &#8212; BioVie Inc., (NASDAQ: BIVI) (\u201cBioVie\u201d or the \u201cCompany\u201d) a clinical-stage company developing innovative drug therapies for the treatment of neurodegenerative disorders and advanced liver disease, today announced the participation of its management team in the Oppenheimer Fall Healthcare Life Sciences &amp; MedTech Virtual Summit September 22, 2021. Details on the conference can be found below. \u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0Oppenheimer Fall Healthcare Life Sciences &amp; MedTech Virtual Summit\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0Format: BioVie Update &amp; Overview\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0Date: Wednesday September 22, 2021\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0Presentation time: 12:25 p.m. EST\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0Webcast: https:\/\/wsw.com\/webcast\/oppenheimer16\/bivi\/2769630 An archived webcast will also be accessible in the Investors section of the company\u2019s website at www.bioviepharma.com. About BioVie BioVie Inc. (NASDAQ: BIVI) is a clinical-stage company developing transformative therapies to overcome unmet medical &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/biovie-to-present-at-oppenheimer-fall-healthcare-life-sciences-medtech-virtual-summit\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;BioVie to Present at Oppenheimer Fall Healthcare Life Sciences &amp; MedTech Virtual Summit&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-538787","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.8 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>BioVie to Present at Oppenheimer Fall Healthcare Life Sciences &amp; MedTech Virtual Summit - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/biovie-to-present-at-oppenheimer-fall-healthcare-life-sciences-medtech-virtual-summit\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"BioVie to Present at Oppenheimer Fall Healthcare Life Sciences &amp; MedTech Virtual Summit - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"SANTA MONICA, Calif., Sept. 15, 2021 (GLOBE NEWSWIRE) &#8212; BioVie Inc., (NASDAQ: BIVI) (\u201cBioVie\u201d or the \u201cCompany\u201d) a clinical-stage company developing innovative drug therapies for the treatment of neurodegenerative disorders and advanced liver disease, today announced the participation of its management team in the Oppenheimer Fall Healthcare Life Sciences &amp; MedTech Virtual Summit September 22, 2021. Details on the conference can be found below. \u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0Oppenheimer Fall Healthcare Life Sciences &amp; MedTech Virtual Summit\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0Format: BioVie Update &amp; Overview\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0Date: Wednesday September 22, 2021\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0Presentation time: 12:25 p.m. EST\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0Webcast: https:\/\/wsw.com\/webcast\/oppenheimer16\/bivi\/2769630 An archived webcast will also be accessible in the Investors section of the company\u2019s website at www.bioviepharma.com. About BioVie BioVie Inc. (NASDAQ: BIVI) is a clinical-stage company developing transformative therapies to overcome unmet medical &hellip; Continue reading &quot;BioVie to Present at Oppenheimer Fall Healthcare Life Sciences &amp; MedTech Virtual Summit&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/biovie-to-present-at-oppenheimer-fall-healthcare-life-sciences-medtech-virtual-summit\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2021-09-15T20:04:07+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODMyNjgwMiM0NDA3NzA4IzUwMDA3OTY2Ng==\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/biovie-to-present-at-oppenheimer-fall-healthcare-life-sciences-medtech-virtual-summit\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/biovie-to-present-at-oppenheimer-fall-healthcare-life-sciences-medtech-virtual-summit\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"BioVie to Present at Oppenheimer Fall Healthcare Life Sciences &amp; MedTech Virtual Summit\",\"datePublished\":\"2021-09-15T20:04:07+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/biovie-to-present-at-oppenheimer-fall-healthcare-life-sciences-medtech-virtual-summit\\\/\"},\"wordCount\":609,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/biovie-to-present-at-oppenheimer-fall-healthcare-life-sciences-medtech-virtual-summit\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODMyNjgwMiM0NDA3NzA4IzUwMDA3OTY2Ng==\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/biovie-to-present-at-oppenheimer-fall-healthcare-life-sciences-medtech-virtual-summit\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/biovie-to-present-at-oppenheimer-fall-healthcare-life-sciences-medtech-virtual-summit\\\/\",\"name\":\"BioVie to Present at Oppenheimer Fall Healthcare Life Sciences &amp; MedTech Virtual Summit - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/biovie-to-present-at-oppenheimer-fall-healthcare-life-sciences-medtech-virtual-summit\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/biovie-to-present-at-oppenheimer-fall-healthcare-life-sciences-medtech-virtual-summit\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODMyNjgwMiM0NDA3NzA4IzUwMDA3OTY2Ng==\",\"datePublished\":\"2021-09-15T20:04:07+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/biovie-to-present-at-oppenheimer-fall-healthcare-life-sciences-medtech-virtual-summit\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/biovie-to-present-at-oppenheimer-fall-healthcare-life-sciences-medtech-virtual-summit\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/biovie-to-present-at-oppenheimer-fall-healthcare-life-sciences-medtech-virtual-summit\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODMyNjgwMiM0NDA3NzA4IzUwMDA3OTY2Ng==\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODMyNjgwMiM0NDA3NzA4IzUwMDA3OTY2Ng==\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/biovie-to-present-at-oppenheimer-fall-healthcare-life-sciences-medtech-virtual-summit\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"BioVie to Present at Oppenheimer Fall Healthcare Life Sciences &amp; MedTech Virtual Summit\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"BioVie to Present at Oppenheimer Fall Healthcare Life Sciences &amp; MedTech Virtual Summit - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/biovie-to-present-at-oppenheimer-fall-healthcare-life-sciences-medtech-virtual-summit\/","og_locale":"en_US","og_type":"article","og_title":"BioVie to Present at Oppenheimer Fall Healthcare Life Sciences &amp; MedTech Virtual Summit - Market Newsdesk","og_description":"SANTA MONICA, Calif., Sept. 15, 2021 (GLOBE NEWSWIRE) &#8212; BioVie Inc., (NASDAQ: BIVI) (\u201cBioVie\u201d or the \u201cCompany\u201d) a clinical-stage company developing innovative drug therapies for the treatment of neurodegenerative disorders and advanced liver disease, today announced the participation of its management team in the Oppenheimer Fall Healthcare Life Sciences &amp; MedTech Virtual Summit September 22, 2021. Details on the conference can be found below. \u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0Oppenheimer Fall Healthcare Life Sciences &amp; MedTech Virtual Summit\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0Format: BioVie Update &amp; Overview\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0Date: Wednesday September 22, 2021\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0Presentation time: 12:25 p.m. EST\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0Webcast: https:\/\/wsw.com\/webcast\/oppenheimer16\/bivi\/2769630 An archived webcast will also be accessible in the Investors section of the company\u2019s website at www.bioviepharma.com. About BioVie BioVie Inc. (NASDAQ: BIVI) is a clinical-stage company developing transformative therapies to overcome unmet medical &hellip; Continue reading \"BioVie to Present at Oppenheimer Fall Healthcare Life Sciences &amp; MedTech Virtual Summit\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/biovie-to-present-at-oppenheimer-fall-healthcare-life-sciences-medtech-virtual-summit\/","og_site_name":"Market Newsdesk","article_published_time":"2021-09-15T20:04:07+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODMyNjgwMiM0NDA3NzA4IzUwMDA3OTY2Ng==","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/biovie-to-present-at-oppenheimer-fall-healthcare-life-sciences-medtech-virtual-summit\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/biovie-to-present-at-oppenheimer-fall-healthcare-life-sciences-medtech-virtual-summit\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"BioVie to Present at Oppenheimer Fall Healthcare Life Sciences &amp; MedTech Virtual Summit","datePublished":"2021-09-15T20:04:07+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/biovie-to-present-at-oppenheimer-fall-healthcare-life-sciences-medtech-virtual-summit\/"},"wordCount":609,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/biovie-to-present-at-oppenheimer-fall-healthcare-life-sciences-medtech-virtual-summit\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODMyNjgwMiM0NDA3NzA4IzUwMDA3OTY2Ng==","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/biovie-to-present-at-oppenheimer-fall-healthcare-life-sciences-medtech-virtual-summit\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/biovie-to-present-at-oppenheimer-fall-healthcare-life-sciences-medtech-virtual-summit\/","name":"BioVie to Present at Oppenheimer Fall Healthcare Life Sciences &amp; MedTech Virtual Summit - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/biovie-to-present-at-oppenheimer-fall-healthcare-life-sciences-medtech-virtual-summit\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/biovie-to-present-at-oppenheimer-fall-healthcare-life-sciences-medtech-virtual-summit\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODMyNjgwMiM0NDA3NzA4IzUwMDA3OTY2Ng==","datePublished":"2021-09-15T20:04:07+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/biovie-to-present-at-oppenheimer-fall-healthcare-life-sciences-medtech-virtual-summit\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/biovie-to-present-at-oppenheimer-fall-healthcare-life-sciences-medtech-virtual-summit\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/biovie-to-present-at-oppenheimer-fall-healthcare-life-sciences-medtech-virtual-summit\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODMyNjgwMiM0NDA3NzA4IzUwMDA3OTY2Ng==","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODMyNjgwMiM0NDA3NzA4IzUwMDA3OTY2Ng=="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/biovie-to-present-at-oppenheimer-fall-healthcare-life-sciences-medtech-virtual-summit\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"BioVie to Present at Oppenheimer Fall Healthcare Life Sciences &amp; MedTech Virtual Summit"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/538787","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=538787"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/538787\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=538787"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=538787"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=538787"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}